Drugs / 68Ga-P16-093
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT06049368 | Oct → Dec 2023 | Sjogren syndrome | Peking Union Medical College Hospital | Unknown | No outcome recorded |
| Phase 1/2 | NCT05569434 | Nov 2021 → Dec 2023 | glioma | Peking Union Medical College Hospital | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT07209865 | Oct 2024 → Dec 2025 | prostate adenocarcinoma | First Affiliated Hospital of Fujian Medical University | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT04796467 | Oct 2020 → Aug 2021 | prostate cancer | Peking Union Medical College Hospital | Unknown | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT05324332 | Apr 2022 → Jan 2025 overdue | prostate cancer | Peking Union Medical College Hospital | Recruiting | No outcome recorded |
| — | NCT05432947 | Apr → Sep 2022 | clear cell renal carcinoma | Peking Union Medical College Hospital | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 68 Ga-P16-093 | “PURPOSE: We aimed to compare the diagnostic performance of 68 Ga-P16-093 and 68 Ga-PSMA-617 PET/CT in primary prostate cancer (PCa) patients.” PMID 36727866 ↗ Jan 2023 |
| Known as | [68 Ga]Ga-P16-093 | “Head-to-head comparison of [(68) Ga]Ga-P16-093 and [(68) Ga]Ga-PSMA-617 in dynamic PET/CT evaluation of the same group of recurrent prostate cancer patients.” PMID 34557930 ↗ Sep 20211“The newly developed PSMA probe, [68Ga]Ga-P16-093, with low urinary excretion, has shown superior diagnostic efficacy compared to conventional PSMA probes.” PMID 41366119 ↗ Dec 2025 |
| Modality | Diagnostic / imaging agent | “Tracer doses of 68Ga-P16-093 will be used to image lesions of prostate cancer by PET/CT.” NCT04796467 ↗ |
| Route | Intravenous | “Intravenous injection of one dosage of 148-185 MBq (4-5 mCi) 68Ga-P16-093.” NCT04796467 ↗ |